About us

Who we are

We are a data-driven Canadian neuroscience and health tech company positioned to globally change the way brain health is managed and treated.

With our rapid, precise scores of cognitive function, we give the brain a voice.

The Team

Dr. John F. Connolly
Dr. John F. Connolly
Chief Science Officer, Co-founder

Dr. Connolly is the co-founder and Chief Science Officer of VoxNeuro. Dr. Connolly provides scientific oversight of VoxNeuro’s technology’s applications in acquired brain injuries, neurological disorders and conditions. He also leads the design of projects to investigate new applications for VoxNeuro’s technology. Dr. Connolly envisions and enables innovative methodologies and technological advances for implementation, such as in unanticipated neuropathological illnesses including COVID-19.

Dr. John Connolly received his PhD from King’s College London and is currently a Professor and Senator William McMaster Chair in Cognitive Neuroscience at McMaster University, Ontario. Dr. Connolly is also the Director of the ARiEAL Research Centre at McMaster and is appointed in the Faculties of Engineering, Science and Humanities. His work has been documented in over 300 peer-reviewed publications and has been supported by funding agencies across the world for almost 40 years. He actively reviews research for a wide range of journals and funding agencies, is a Faculty Affiliate at the Vector Institute of Artificial Intelligence, and is a member of Brain Injury Canada’s Scientific Advisory Committee.

James Connolly
James Connolly
Chief Executive Officer, Co-founder

James is the co-founder and CEO of VoxNeuro. James leads VoxNeuro’s overarching strategy and ensures operations remain focused and accelerated. Whether it be employees, clients, partners, investors, or patients, James dedicates his time to serving VoxNeuro’s stakeholders and building out VoxNeuro’s ability to grow its presence and support the communities VoxNeuro serves.

Before co-founding VoxNeuro in 2017 James spent the first nine years of his career in commercial development roles across various industries including automotive, financial, media, and healthcare. Most recently James led US client development for Dentsu Aegis Network, the 3rd largest media conglomerate in the world. Leading their US client team, James led strategic initiatives to drive growth for their largest US accounts including Pfizer, Microsoft, Diageo, and Northrop Grumman. James completed his studies with a speciality in business process integration from the Hogeschool van Amsterdam and a B.Comm. from the University of Ottawa’s Telfer School of Management in 2010.

Kimberly Elliott
Chief Operating Officer, Co-founder

Kimberly is a co-founder and Chief Operating Officer of VoxNeuro. Kimberly works directly with the CEO and Board of Directors to develop and manage VoxNeuro’s strategic and operational plans, executing on VoxNeuro’s goals for performance and growth. Kimberly oversees business operations as a whole with focus on Legal, Finance, Communications, Clinical Operations, Human Relations, and Corporate Social Responsibility in concert with department leads.

Before founding VoxNeuro, Kimberly made her career in account management at leading creative advertising agencies including DentsuBos in Toronto and mcgarrybowen in New York. From managing clients including JCPenney in the US market, and Canon and Manulife in Canada, Kimberly developed strong skills in communications, strategy, budget and project management – keeping clients and her teams focused, on time and on budget.

Kimberly was born in Calgary and grew up primarily overseas in The Netherlands and Malaysia before returning to Canada for university and to start her career. With a world view engrained in her thinking, she’s laser focused on the global impact VoxNeuro will have on how brain health is managed.

Sam Chebib
Sam Chebib
Chief Strategist

As Chief Strategist, Sam is responsible for driving the development of VoxNeuro’s long term strategy alongside the Executive team, with a focus on growing shareholder value.

Sam Chebib was the President and Chief Executive Officer of Nightingale since he founded the company in 2002. Under his guidance the company became a cloud-based EHR leader in North America. Nightingale was number one on the Deloitte Fast 50 in Canada, number ten on the Deloitte Fast 500 in North America and ranked as the third largest Healthcare Information Technology company on the Branham 300. Nightingale was acquired by Telus Health in 2016 and Sam joined VoxNeuro shortly after.

Doug Watt
Doug Watt
Chief Revenue Officer

As Chief Revenue Officer, Doug oversees sales, marketing and customer engagement to drive VoxNeuro’s national and international expansion strategy through the growth of VoxNeuro’c clinical network.

Doug has spent the majority of his career in Consulting and Software, with the last 20 years focused on Healthcare. Before joining VoxNeuro, Doug worked at Deloitte, where as a Senior Advisor to the Digital Health team he led large programs with the Ontario Ministry of Health, Alberta Health and BC Ministry of Health.

Prior to Deloitte, Doug spent 6.5 years with eHealth Ontario. As Senior Vice President overseeing Product Management and Account Management, he drove the Agency’s Digital Health and Clinical Data solutions. Doug held a number of executive positions with Nightingale Informatix in the years prior, leading adoption of innovative technologies at healthcare organizations and physicians’ practices.

Dr. Kyle I. Ruiter
Dr. Kyle I. Ruiter
Vice President, Clinical & Scientific Affairs

As Vice President, Clinical & Scientific Affairs, Kyle is responsible for ensuring the highest standard of care for patients through the strategic leadership of VoxNeuro’s clinical and scientific practices. This includes the oversight of the Research & Development, Clinical Operations and Regulatory Affairs & Quality Assurance departments, with a focus on product development and expanding the medical applications of VoxNeuro’s technology.

Dr. Ruiter was awarded his Ph.D. from McMaster University’s Cognitive Science of Language Program. Dr. Ruiter received extensive training in cognitive neuroscience; specifically, with expertise in electrophysiology and the neurophysiological consequences of concussion and other traumatic brain injuries (TBIs). He has been published in numerous peer-reviewed journals for his research in brain injury and neuroimaging. Additionally, Dr. Ruiter is well-versed in regulatory affairs; in particular, medical device hardware and software regulation for both Health Canada (HC) and the FDA. In addition to his PhD, Dr. Ruiter holds a diploma in General Arts and Science from Humber College, a Honours Bachelor’s of Applied Science in Psychology with an emphasis in Business Administration from the University of Guelph, as well as a post-graduate certificate in Regulatory Affairs from Algonquin College.

Christopher Seminerio
Christopher Seminerio
Director of Account Management, Sales & Strategic Partnerships

As Director of Account Management, Christopher leads the business development team growing VoxNeuro’s services in private clinics, hospital networks & pharmaceutical companies. He also builds research initiatives focused in hospital & university networks.

Christopher has 10+ years experience as a professional corporate sales representative in consumer packaged goods with Frito Lay Canada, technology and services with Xerox Canada and in supply chain and logistics with Purolator. He graduated from the University of Ottawa with a Bachelor of Commerce in Marketing.

After spending the majority of the first 23 years of his life in Canada Christopher promptly moved to South Korea upon graduation. He left behind the prospects of a great job to experience a new challenge by being introduced to a new culture while making connections that expand the globe today. What motivates Christopher most is taking groundbreaking technology that is backed by world class research from a renowned science team is an exciting opportunity to be a part of. VoxNeuro is pushing the understanding of the brain and providing a technology that will help millions of people suffering from cognitive issues. Also being a part of a young, driven, mission focused team that wants to help people.

Alyshia Laidlaw
Alyshia Laidlaw
Business Development Coordinator, Sales & Strategic Partnerships

Alyshia is a recent graduate from McMaster University. She earned her Bachelor of Health Science in Biomedical Discovery and Commercialization. Her previous work experience has been in both science and business; from conducting research in a lab to working as a finance intern at Scotiabank. Alyshia is working with the Sales and Strategic Partnerships team for the summer and is excited to assist with market research and client outreach. She will be returning to pursue a master’s degree at McMaster in the fall.

Austen Remme
Austen Remme
Software Developer, Product Development

Austen is responsible for supporting the AI & Technology and Clinical Operations teams at VoxNeuro, by providing software development expertise and assisting with integration and support for the IT and business ecosystems.

Before VoxNeuro, Austen worked as an application specialist, providing application support to employees across Canada and streamlining automation by developing in-house testing software.

Prior to completing a B.Cmp at Queen’s School of Computing, Austen attended the National Ski Academy in Collingwood, where he raced in various international competitions and trained at ski resorts across North America and Europe.

Andrew Matiasso
Andrew Matiasso, CHT™
Senior Manager, Clinical & Scientific Affairs

Andrew is responsible for ensuring high standards of care for patients through the strategic leadership of clinical personnel, compliance with regulatory bodies, and the optimization of operational practices in clinical and research contexts.

Prior to VoxNeuro, Andrew worked as a Registered Kinesiologist, prescribing exercise in clinical and general populations. He completed a BSc in Kinesiology at the University of Guelph-Humber.

Danielle Gnidec
Danielle Gnidec, OTA/PTA, CHT™
Manager, Clinical Operations

Danielle manages VoxNeuro’s clinical and professional practice education, including oversight and provision of quality and client centred care with VoxNeuro’s partners. As Manager of Clinical Education, Danielle proactively assesses and determines education programming for VoxNeuro’s clinical partners, is responsible for performance evaluation of clinical staff, develops learning plans, and delivers and evaluates practice education in support of the goals and objectives of VoxNeuro.

Before working at VoxNeuro, Danielle was an OTA/PTA with a number of rehabilitation clinics around the GTA. Danielle received her OTA/PTA certificate from Humber College.

Douglas Martin
Douglas Martin
Brand Manager

As Brand Manager, Douglas’ primary focus lies in driving marketing and communication initiatives, acting as the primary contact for advertising and public relations partners, managing internal communications, and collaborating with the Sales, Clinical & Scientific Affairs, and Product Development teams to maintain a consistent brand strategy.

Douglas graduated from the University of Guelph with a Bachelor of Commerce, earning Dean’s List honours. Before joining the VoxNeuro team in August 2021, Douglas spent seven years in account management in the advertising industry, leading business for clients across various sectors, including financial, automotive, consumer packaged goods and retail.

Kung Chu
Kung Chu
Digital Marketing Lead, Communications

As Digital Marketing Lead, Kung works directly with the COO to develop and manage VoxNeuro’s digital marketing strategy. Kung executes VoxNeuro’s digital marketing campaigns across a variety of channels from Paid Search, Social Media, and Display advertising. Kung has over 7 years of agency and client side across healthcare, automotive, consumer electronics, and financial services.

Industry Partners & Support

McMaster University

VoxNeuro’s science is backed by over 30 years of globally funded, peer-reviewed research led by Dr. John F. Connolly. This research began at Dalhousie University, furthered at University of Montreal, and continues to break new ground at McMaster University, where VoxNeuro launched its operations in 2017. VoxNeuro works with partners at the McMaster Industry Liaison Office in the commercialization of Dr. Connolly’s research, and is a graduate of The Forge, McMaster’s start-up incubator.

National Research Council Canada

VoxNeuro has received innovation support funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). Obtaining NRC IRAP funding not only serves as recognition for VoxNeuro’s focus on innovation, but also served as a catalyst for the company’s growth and ability to scale, funding the development of the Cognitive Health Assessment Management Platform™.

2021 Hamilton Chamber of Commerce

VoxNeuro is a member of the Hamilton Chamber of Commerce. As a part of the Hamilton community, VoxNeuro is dedicated to building Hamilton’s reputation as one of Canada’s leading innovative cities in healthcare, while helping to promote and enhance business growth and activities across the City of Hamilton.

Brain Injury Canada Platinum Sponsorship

VoxNeuro is a Platinum Corporate Sponsor of Brain Injury Canada. The organizations share the central mission to enhance the lives of individuals, their families & caregivers living with brain injury. Brain Injury Canada, the only national charitable brain injury organization, enables access to ABI information and services for all Canadians.

VoxNeuro and the Canadian Football League Alumni Association have a collaboration agreement to offer the Cognitive Health Assessment™ to its members. Through the partnership, these groups will also raise awareness of long term impacts of head trauma, like concussion. For ageing Canadians who have experienced head-trauma throughout their lives, a growing concern is understanding its relationship with cognitive decline.

The Government of Canada’s Trade Commissioner Service selected VoxNeuro as 1 of 11 emerging growth Canadian Life Sciences companies to participate in the Canadian Technology Accelerators’ inaugural bi-coastal program led by the Consulates General of Canada in New York and San Francisco. The program, which concluded in November 2020, was dedicated to the development of high-potential, early-stage digital health start-ups into the San Francisco and New York healthcare ecosystems, priming VoxNeuro’s US market entry in 2021.

Creating Change with VoxNeuro

VoxNeuro’s mission at its core is about creating change. VoxNeuro is dedicated to improving the world’s understanding of the brain through objective measurement of core cognitive functions. A benefit of VoxNeuro’s Cognitive Health Assessment™ is that it facilitates access to care. VoxNeuro’s technology arms healthcare teams with objective data to objectively inform clinical decision-making and advocate for their patient’s treatment.

In removing reliance on subjective assessments traditionally used to assess the brain, VoxNeuro’s technology gives an objective voice to otherwise invisible brain ailments. In the same manner, objective and representative data across all healthcare has the power to give a voice to patient populations who have been disproportionately affected by gaps in the healthcare system.

VoxNeuro is made up of a team who were all brought on because of their unique backgrounds. We celebrate each other’s unique lived experiences and differences, and know that this is what gives the team strength. We are the team that we are because of each other’s voices, compassion and support. This is core to our culture. Together, we are dedicated to being change agents for marginalized communities, and hope we inspire others to do what is within their power to act and to create permanent, positive, inclusive solutions.

Amplifying voices of diversity

While we strive for diversity, equity and inclusion internally, we’re taking advantage of the fact that there are a lot of eyes on our growing company. We have launched a content series dedicated to recognizing researchers and healthcare practitioners of color in the field of neuroscience and healthcare. The goal of the series is to help educate on the challenges and gaps in brain-centred healthcare for marginalized communities.

VoxNeuro is actively seeking individuals to get involved in this initiative. If you are interested in being interviewed, or have someone you’d like to nominate, please contact us at [email protected]

Read VoxNeuro’s statements on anti-Asian and anti-black racism that inspired this content series.

Sign-up for VoxNeuro’s Newsletter